MedPath

does a regional hip anesthesia technique reduce pain after hip arthroplasty

Conditions
Our hypothesis is that a longitudinal approach to the fascia iliaca with a larger volume of local anesthetic will decrease morphine consumption and pain scores in patients after total hip arthroplasty compared to a control group.We will test our hypothesis in a double blind, randomized, placebo controlled trial.
MedDRA version: 17.0Level: LLTClassification code 10044088Term: Total hip replacementSystem Organ Class: 100000004865
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2014-002122-12-BE
Lead Sponsor
az turnhout
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

After obtaining written, informed consent patients presenting for primary THA will be included in the study.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 44
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range 44

Exclusion Criteria

Exclusion criteria will be age <18years, BMI>35, intolerance to any of the drugs used in the study, opioid dependency and coagulopathy.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: The primary endpoint of the study will be total morfine consumption during the first 24 hours. <br><br>;Secondary Objective: Secondary endpoints will be morphine consumption at 48 hours, pain scores, postoperative nausea and vomiting and number of blocked nerves using respons to pinprick in the sensory territories of the different nerves (femoral, obturator and lateral cutaneous).;Primary end point(s): The primary endpoint of the study will be total morfine consumption during the first 24 hours. ;Timepoint(s) of evaluation of this end point: Total Morphine consumption at 24 hours.
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): Secondary endpoints will be morphine consumption at 48 hours, pain scores, postoperative nausea and vomiting and number of blocked nerves using respons to pinprick in the sensory territories of the different nerves (femoral, obturator and lateral cutaneous).;Timepoint(s) of evaluation of this end point: Total Morphine consumption at 48 hours.
© Copyright 2025. All Rights Reserved by MedPath